Targeted therapies have changed non-small cell lung cancer care, but new side effects, like weight gain, are emerging, says Dr. Lorenzo Belluomini.
Dr. Lorenzo Belluomini
Advertisement
Articles by Dr. Lorenzo Belluomini
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Inluriyo for ER+, HER2– Metastatic Breast Cancer
2
New Drug Combo Shows Deeper Responses in Multiple Myeloma
3
First-Line Enhertu Combo Gets Priority Review in HER2+ Metastatic Breast Cancer
4
Understanding Early Warning Signs of Prostate Cancer
5
